Recent advancements in biosensor designs toward the detection of intestine cancer miRNA biomarkers.

Cancer diagnosis and treatment have been of broad interest among scientists in the last decades due to the high death rate, widespread occurrence, and recurrence after treatment. The survival rate of cancer patients depends greatly on early detection and appropriate treatments. Therefore developing new technologies applicable to sensitive and specific methods of cancer detection is an inevitable task for cancer researchers. Abnormal miRNA expression is contributed to severe diseases such as cancers and since their expression level and type differ strictly during carcinogenesis and later metastasis and treatments, the improved detection accuracy of these miRNAs would undoubtedly lead to early diagnosis, prognosis, and targeted therapy. Biosensors are accurate and straightforward analytical devices that have had practical applications especially in the last decade. Their domain is still growing through a combination of attractive nanomaterials and amplification methods, leading to innovative biosensing platforms for the efficient detection of miRNAs as diagnostic and prognostic biomarkers. In this review, we will provide the recent developments in biosensors to detect intestine cancer miRNA biomarkers and also discuss the challenges and outcomings of this field. • Intestinal cancer is one of the commonly diagnosed cancers and leading cause of death worldwide. • The feasibility of miRNAs as promising cancer biomarkers was confirmed. • Rapid and sensitive detection of miRNAs is helpful for early detection of intestine cancer. • The emergence of biosensors provides a cheap, sensitive, less invasive tool for detecting miRNA biomarkers. • Improvements in the detection approaches for intestinal miRNAs are reviewed here. [ABSTRACT FROM AUTHOR]